Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1998-5-13
pubmed:abstractText
The present study reveals that partial proteolytic degradation of rat Muc 2 mucin can occur rapidly even in the presence of a battery of proteinase inhibitors. During the initial steps of purification from homogenates of intestinal scrapings, degradation was rapid, causing release of the entire 118 kDa C-terminal glycopeptide and, as shown by N-terminal sequencing, a large (200 kDa) N-terminal glycopeptide fragment. Degradation could be prevented by adding 6 M guanidinium chloride provided that its presence was maintained throughout every step of purification. Even after purification, however, the mucin was still vulnerable to partial proteolysis unless it was stored in guanidinium chloride at -20 degrees C. These findings imply that a potent proteinase contaminant remains tightly bound to the mucin through every step of purification, or else that the mucin has autocatalytic properties. Because the C- and N-terminal regions of secretory mucins are required for their assembly into linear mucin polymers that form functional gels, our findings emphasize that extreme care is required to purify structurally intact mucin molecules. They also imply that the specific degradation steps described here are likely to occur rapidly after mucins are secreted into the intestinal lumen and come into contact with the products of sloughed cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1371999, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1379596, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1380841, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1400449, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1456650, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1550588, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1556125, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1727693, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-1888015, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2033060, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2064605, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-208893, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2111320, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2302164, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2701480, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-2775239, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3178222, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3201095, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3311021, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3346246, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3435452, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3706710, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-3800974, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-4019034, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6083849, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6162199, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6374870, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6409086, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6517857, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6615445, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6756314, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-6847606, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-7044058, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-7491952, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-7674925, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-8027037, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-8348238, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-8360170, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-8415927, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-8576161, http://linkedlifedata.com/resource/pubmed/commentcorrection/9512496-9056200
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
331 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
323-30
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Susceptibility of the cysteine-rich N-terminal and C-terminal ends of rat intestinal mucin muc 2 to proteolytic cleavage.
pubmed:affiliation
Research Institute, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't